Selected research
Market Structure
Global Radix Isatidis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Radix Isatidis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Radix Isatidis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Radix Isatidis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radix Isatidis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Radix Isatidis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Radix Isatidis include Revised Pharmaceutical Group Limited by Share Ltd, Guangzhou Baiyun Mountain Pharmaceutical Group, Guangzhou Xiangxue pharmaceutical Limited by Share Ltd, Huarun 39 pharmaceuticals Limited by Share Ltd, Anhui Hua Tuo national drug Limited by Share Ltd, Jilin Aodong Pharmaceutical Group Corporation, Li Shizhen Medical Group Ltd, Taiji Group Ltd and Yunnan Baiyao Group Limited by Share Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Radix Isatidis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Radix Isatidis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Radix Isatidis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radix Isatidis market size, projected growth trends, production technologies, key applications, and end-use industries.
Radix Isatidis Segment by Company
Revised Pharmaceutical Group Limited by Share Ltd
Guangzhou Baiyun Mountain Pharmaceutical Group
Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
Huarun 39 pharmaceuticals Limited by Share Ltd
Anhui Hua Tuo national drug Limited by Share Ltd
Jilin Aodong Pharmaceutical Group Corporation
Li Shizhen Medical Group Ltd
Taiji Group Ltd
Yunnan Baiyao Group Limited by Share Ltd
China Beijing Tongrentang (Group) Co., Ltd.
Radix Isatidis Segment by Type
Grain
Capsule
Other
Radix Isatidis Segment by Application
Pharmacy
Hospital
Other
Radix Isatidis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radix Isatidis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radix Isatidis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radix Isatidis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radix Isatidis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radix Isatidis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radix Isatidis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Radix Isatidis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Grain
- Capsule
- Other
Applications
- Pharmacy
- Hospital
- Other
Companies covered
- Revised Pharmaceutical Group Limited by Share Ltd
- Guangzhou Baiyun Mountain Pharmaceutical Group
- Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
- Huarun 39 pharmaceuticals Limited by Share Ltd
- Anhui Hua Tuo national drug Limited by Share Ltd
- Jilin Aodong Pharmaceutical Group Corporation
- Li Shizhen Medical Group Ltd
- Taiji Group Ltd
- Yunnan Baiyao Group Limited by Share Ltd
- China Beijing Tongrentang (Group) Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Radix Isatidis Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Radix Isatidis Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Radix Isatidis Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Radix Isatidis Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Radix Isatidis Market Dynamics
- 2.1 Radix Isatidis Industry Trends
- 2.2 Radix Isatidis Industry Drivers
- 2.3 Radix Isatidis Industry Opportunities and Challenges
- 2.4 Radix Isatidis Industry Restraints
3 Radix Isatidis Market by Manufacturers
- 3.1 Global Radix Isatidis Revenue by Manufacturers (2021-2026)
- 3.2 Global Radix Isatidis Sales by Manufacturers (2021-2026)
- 3.3 Global Radix Isatidis Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Radix Isatidis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Radix Isatidis Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Radix Isatidis Manufacturers, Product Type & Application
- 3.7 Global Radix Isatidis Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Radix Isatidis Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Radix Isatidis Players Market Share by Revenue in 2025
- 3.8.3 2025 Radix Isatidis Tier 1, Tier 2, and Tier 3
4 Radix Isatidis Market by Type
- 4.1 Radix Isatidis Type Introduction
- 4.1.1 Grain
- 4.1.2 Capsule
- 4.1.3 Other
- 4.2 Global Radix Isatidis Sales by Type
- 4.2.1 Global Radix Isatidis Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Radix Isatidis Sales by Type (2021-2032)
- 4.2.3 Global Radix Isatidis Sales Market Share by Type (2021-2032)
- 4.3 Global Radix Isatidis Revenue by Type
- 4.3.1 Global Radix Isatidis Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Radix Isatidis Revenue by Type (2021-2032)
- 4.3.3 Global Radix Isatidis Revenue Market Share by Type (2021-2032)
5 Radix Isatidis Market by Application
- 5.1 Radix Isatidis Application Introduction
- 5.1.1 Pharmacy
- 5.1.2 Hospital
- 5.1.3 Other
- 5.2 Global Radix Isatidis Sales by Application
- 5.2.1 Global Radix Isatidis Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Radix Isatidis Sales by Application (2021-2032)
- 5.2.3 Global Radix Isatidis Sales Market Share by Application (2021-2032)
- 5.3 Global Radix Isatidis Revenue by Application
- 5.3.1 Global Radix Isatidis Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Radix Isatidis Revenue by Application (2021-2032)
- 5.3.3 Global Radix Isatidis Revenue Market Share by Application (2021-2032)
6 Global Radix Isatidis Sales by Region
- 6.1 Global Radix Isatidis Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Radix Isatidis Sales by Region (2021-2032)
- 6.2.1 Global Radix Isatidis Sales by Region (2021-2026)
- 6.2.2 Global Radix Isatidis Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Radix Isatidis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Radix Isatidis Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Radix Isatidis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Radix Isatidis Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Radix Isatidis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Radix Isatidis Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Radix Isatidis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Radix Isatidis Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Radix Isatidis Revenue by Region
- 7.1 Global Radix Isatidis Revenue by Region
- 7.1.1 Global Radix Isatidis Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Radix Isatidis Revenue by Region (2021-2026)
- 7.1.3 Global Radix Isatidis Revenue by Region (2027-2032)
- 7.1.4 Global Radix Isatidis Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Radix Isatidis Revenue (2021-2032)
- 7.2.2 North America Radix Isatidis Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Radix Isatidis Revenue (2021-2032)
- 7.3.2 Europe Radix Isatidis Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Radix Isatidis Revenue (2021-2032)
- 7.4.2 Asia-Pacific Radix Isatidis Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Radix Isatidis Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Radix Isatidis Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Revised Pharmaceutical Group Limited by Share Ltd
- 8.1.1 Revised Pharmaceutical Group Limited by Share Ltd Company Information
- 8.1.2 Revised Pharmaceutical Group Limited by Share Ltd Business Overview
- 8.1.3 Revised Pharmaceutical Group Limited by Share Ltd Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Revised Pharmaceutical Group Limited by Share Ltd Radix Isatidis Product Portfolio
- 8.1.5 Revised Pharmaceutical Group Limited by Share Ltd Recent Developments
- 8.2 Guangzhou Baiyun Mountain Pharmaceutical Group
- 8.2.1 Guangzhou Baiyun Mountain Pharmaceutical Group Company Information
- 8.2.2 Guangzhou Baiyun Mountain Pharmaceutical Group Business Overview
- 8.2.3 Guangzhou Baiyun Mountain Pharmaceutical Group Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Guangzhou Baiyun Mountain Pharmaceutical Group Radix Isatidis Product Portfolio
- 8.2.5 Guangzhou Baiyun Mountain Pharmaceutical Group Recent Developments
- 8.3 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
- 8.3.1 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Company Information
- 8.3.2 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Business Overview
- 8.3.3 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Radix Isatidis Product Portfolio
- 8.3.5 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Recent Developments
- 8.4 Huarun 39 pharmaceuticals Limited by Share Ltd
- 8.4.1 Huarun 39 pharmaceuticals Limited by Share Ltd Company Information
- 8.4.2 Huarun 39 pharmaceuticals Limited by Share Ltd Business Overview
- 8.4.3 Huarun 39 pharmaceuticals Limited by Share Ltd Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Huarun 39 pharmaceuticals Limited by Share Ltd Radix Isatidis Product Portfolio
- 8.4.5 Huarun 39 pharmaceuticals Limited by Share Ltd Recent Developments
- 8.5 Anhui Hua Tuo national drug Limited by Share Ltd
- 8.5.1 Anhui Hua Tuo national drug Limited by Share Ltd Company Information
- 8.5.2 Anhui Hua Tuo national drug Limited by Share Ltd Business Overview
- 8.5.3 Anhui Hua Tuo national drug Limited by Share Ltd Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Anhui Hua Tuo national drug Limited by Share Ltd Radix Isatidis Product Portfolio
- 8.5.5 Anhui Hua Tuo national drug Limited by Share Ltd Recent Developments
- 8.6 Jilin Aodong Pharmaceutical Group Corporation
- 8.6.1 Jilin Aodong Pharmaceutical Group Corporation Company Information
- 8.6.2 Jilin Aodong Pharmaceutical Group Corporation Business Overview
- 8.6.3 Jilin Aodong Pharmaceutical Group Corporation Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Jilin Aodong Pharmaceutical Group Corporation Radix Isatidis Product Portfolio
- 8.6.5 Jilin Aodong Pharmaceutical Group Corporation Recent Developments
- 8.7 Li Shizhen Medical Group Ltd
- 8.7.1 Li Shizhen Medical Group Ltd Company Information
- 8.7.2 Li Shizhen Medical Group Ltd Business Overview
- 8.7.3 Li Shizhen Medical Group Ltd Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Li Shizhen Medical Group Ltd Radix Isatidis Product Portfolio
- 8.7.5 Li Shizhen Medical Group Ltd Recent Developments
- 8.8 Taiji Group Ltd
- 8.8.1 Taiji Group Ltd Company Information
- 8.8.2 Taiji Group Ltd Business Overview
- 8.8.3 Taiji Group Ltd Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Taiji Group Ltd Radix Isatidis Product Portfolio
- 8.8.5 Taiji Group Ltd Recent Developments
- 8.9 Yunnan Baiyao Group Limited by Share Ltd
- 8.9.1 Yunnan Baiyao Group Limited by Share Ltd Company Information
- 8.9.2 Yunnan Baiyao Group Limited by Share Ltd Business Overview
- 8.9.3 Yunnan Baiyao Group Limited by Share Ltd Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Yunnan Baiyao Group Limited by Share Ltd Radix Isatidis Product Portfolio
- 8.9.5 Yunnan Baiyao Group Limited by Share Ltd Recent Developments
- 8.10 China Beijing Tongrentang (Group) Co., Ltd.
- 8.10.1 China Beijing Tongrentang (Group) Co., Ltd. Company Information
- 8.10.2 China Beijing Tongrentang (Group) Co., Ltd. Business Overview
- 8.10.3 China Beijing Tongrentang (Group) Co., Ltd. Radix Isatidis Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 China Beijing Tongrentang (Group) Co., Ltd. Radix Isatidis Product Portfolio
- 8.10.5 China Beijing Tongrentang (Group) Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Radix Isatidis Value Chain Analysis
- 9.1.1 Radix Isatidis Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Radix Isatidis Production Mode & Process
- 9.2 Radix Isatidis Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Radix Isatidis Distributors
- 9.2.3 Radix Isatidis Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst